Bristol-Myers Squibb Co (XSWX:BMY) 3-Year EBITDA Growth Rate

: 62.20% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Bristol-Myers Squibb Co's EBITDA per Share for the three months ended in Dec. 2023 was CHF1.73.

During the past 12 months, Bristol-Myers Squibb Co's average EBITDA Per Share Growth Rate was 4.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 62.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bristol-Myers Squibb Co was 62.20% per year. The lowest was -26.00% per year. And the median was 8.95% per year.

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co 3-Year EBITDA Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's 3-Year EBITDA Growth Rate falls into.

Bristol-Myers Squibb Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bristol-Myers Squibb Co (XSWX:BMY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bristol-Myers Squibb Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (XSWX:BMY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XSWX:BMY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.